Baricitinib (Olumiant)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Baricitinib (Olumiant), covering 2025-05-13 to 2026-03-17. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis [Phase 3]